COMMUNIQUÉS West-GlobeNewswire

FibroBiologics to Present at 2025 Cell & Gene Meeting on the Mesa
23/09/2025
HOUSTON, Sept. 23, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of [...]
Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System
23/09/2025
Livestream Interview Can be Viewed on September 24th at 10:45am ET at Benzinga All Access Live HINGHAM, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and manufacturer of the [...]
Aphaia Pharma Publishes Phase 1 and 2 Clinical Data of Oral Formulation in Patients with Obesity and Prediabetes
23/09/2025
Aphaia’s lead formulation orchestrates a comprehensive hormonal response from nutrient-sensing cells with potential to modify the course of obesity and associated metabolic diseases. It is currently under evaluation in [...]
SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children
23/09/2025
DENVER, Sept. 23, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today that preliminary results from the SAVE Surveillance Registry will be [...]
IO Biotech Announces Late-Breaking Abstract in Advanced Melanoma Selected for Oral Presentation at ESMO Congress 2025
23/09/2025
Oral presentation will highlight the results from the randomized Phase 3 trial (IOB-013/KN-D18) of IO102-IO103 cancer vaccine plus pembrolizumab for first-line (1L) advanced melanoma Poster presentation will share final [...]
Mainz Biomed Announces Commercial Launch of ColoAlert® in Switzerland
23/09/2025
Company Provides Update on eAArly DETECT 2 Study BERKELEY, Calif. and MAINZ, Germany, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic [...]
Innovate GBM’s 2025 Investment Playbook Year to Date Review: Building a New Market for Brain Cancer Investments and Breakthroughs
23/09/2025
LOS ANGELES, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Innovate GBM , a 501(c)(3) nonprofit dedicated to transforming the landscape of brain tumor research, investment, and treatment, has released its 2025 Year-to-Date Impact [...]
Branded Legacy Inc. Unveils Cutting-Edge GMP Facility to Accelerate Life-Saving Inhaled Naloxone Development
23/09/2025
BioLegacy's New Vancouver Hub Drives Innovation in Opioid Crisis Solutions with Unmatched Manufacturing and Research Capabilities VANCOUVER, British Columbia, Sept. 23, 2025 (GLOBE NEWSWIRE) -- via IBN – BioLegacy [...]
Remedy's Nutrition® Launches Advanced Herbal Parasite Cleanse Formula to Support Natural Digestive Wellness and Internal Cleansing
23/09/2025
KEY LARGO, Fla., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Remedy's Nutrition®, a trusted natural dietary supplement company since 1972 and a leader in premium herbal formulations, today announced the launch of its powerful [...]
CMS Grants Transitional Pass-Through Status for Gozellix
23/09/2025
MELBOURNE, Australia and INDIANAPOLIS, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the United States (U.S.) Centers for Medicare & Medicaid [...]
Human Appeal USA Expands its Domestic Programs with New Locations in Maryland and Virginia to Mobilize Humanitarian Support Nationwide
23/09/2025
The nonprofit reached over 6.2 million people globally with relief aid last year BALTIMORE, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Human Appeal USA , a leading global humanitarian aid organization, proudly announces the [...]
Trethera Receives $1.8 Million NIH Grant to Advance TRE-515 Development for Crohn’s Disease
23/09/2025
LOS ANGELES, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, announced today that [...]
H.H.C. Group Launches “Proof in the Pudding” Savings Program for Prospective Client TPAs, Stop-Loss and Self-Insured Payors
23/09/2025
ROCKVILLE, Md., Sept. 23, 2025 (GLOBE NEWSWIRE) -- H.H.C. Group (H.H.C.), a leader in reducing healthcare costs by providing high-quality cost containment solutions, proudly announces the launch of its new “Proof in the [...]
Plum Tree Leads the Way in Team-Based Child Therapy and Multidisciplinary Testing
23/09/2025
ST. CHARLES, IL, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Plum Tree Psychology, a trusted child and family mental health practice in St. Charles, IL, is proud to announce the launch of its multidisciplinary evaluation service [...]
Scilex Holding Company Announces Signing of a Securities Purchase Agreement with an Institutional Investor to Exchange $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held By Scilex Holding Company for $200 Million in Bitcoin
23/09/2025
PALO ALTO, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]
Biofrontera Inc. Engages Lytham Partners to Lead Strategic Investor Relations and Shareholder Communication Program
23/09/2025
WOBURN, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”) , a biopharmaceutical company specializing in the development and commercialization of photodynamic [...]
Major Shareholder Announcement
23/09/2025
Company Announcement Major shareholder announcement for Genmab A/S COPENHAGEN, Denmark; September 23, 2025 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that Orbis [...]
Fifty 1 Labs, Inc. Engages PCAOB Auditing Firm to Prepare for Uplist to OTCQB
23/09/2025
Fifty 1 Labs continues to advance its portfolio of biotech and wellness initiatives VANCOUVER, British Columbia, Sept. 23, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 Labs, Inc, ( OTC:FITY ) a Nevada-based holding [...]
Confluent Health Appoints Jim Greenwood as New Board Chair
23/09/2025
Veteran healthcare executive to lead Board of Directors as company accelerates national growth in musculoskeletal care LOUISVILLE, Ky., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Confluent Health , a national leader in [...]

Pages